Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029314 · ClinicalTrials.gov registry record
Pilot Study of the Genius(TM)2 Tympanic Thermometer in Cardiac Patients Requiring Cardiopulmonary Bypass
A clinical trial of Cardiac Surgical Procedures, sponsored by Tyco Healthcare Group.
- Completed
- Registry status
- 33
- Enrollment target
- 1
- Study location
NCT01029314: Completed study of Cardiac Surgical Procedures, sponsored by Tyco Healthcare Group.
NCT01029314 is a study of Cardiac Surgical Procedures that has completed, run by Tyco Healthcare Group. The registered enrollment target is 33 participants, below the 188-participant average among 3 other Cardiac Surgical Procedures trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01029314, a study of Cardiac Surgical Procedures, has completed, sponsored by Tyco Healthcare Group.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary study objective is to test the accuracy of the Genius 2 tympanic thermometer and the Exergen TAT-5000(TM) temporal artery thermometer as compared with serial perioperative core temperature measurements obtained in cardiac surgical patients during cardiopulmonary bypass. Study hypothesis: The Genius 2 thermometer will display greater precision and accuracy than the Exergen TAT-5000 thermometer when compared to core body temperature in patients undergoing CABG surgery.
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-06 |
What the finished NCT01029314 record still lists
NCT01029314 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 188-participant average among 3 other Cardiac Surgical Procedures trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cardiac Surgical Procedures appearing as the primary indexed condition, and to 0 interventions.
NCT01029314 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01029314 about?
NCT01029314 is a clinical study titled "Pilot Study of the Genius(TM)2 Tympanic Thermometer in Cardiac Patients Requiring Cardiopulmonary Bypass". Primary study objective is to test the accuracy of the Genius 2 tympanic thermometer and the Exergen TAT-5000(TM) temporal artery thermometer as compared with serial perioperative core temperature measurements obtained in cardiac surgical patients during cardiopulmonary bypass. Study hypothesis: The...
What is the current status of trial NCT01029314?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2008-05. Estimated completion is 2009-06.
What conditions does trial NCT01029314 study?
This clinical trial studies the following conditions: Cardiac Surgical Procedures.
Who is sponsoring clinical trial NCT01029314?
This trial is sponsored by Tyco Healthcare Group, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01029314 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgical Procedures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia